TS2523010558	drug 4 33	glucokinase activator AZD6370
TS1823010558	drugEffect 34 76	decreases fasting and postprandial glucose
TS2623010558	treatedDisease 80 104	type 2 diabetes mellitus
TS2123010558	food 160 164	food
TS1123010558	drug 240 269	glucokinase activator AZD6370
TS1223010558	mealTime 306 309	fed
TS1523010558	mealTime 314 331	fasted conditions
TS123010558	treatedDisease 349 373	type 2 diabetes mellitus
TS3223010558	mealTime 513 519	fasted
TS423010558	mealTime 523 526	fed
TS1723010558	drug 690 697	insulin
TS3123010558	mealTime 848 854	fasted
TS523010558	mealTime 859 862	fed
TS823010558	drug 915 922	Insulin
TS3323010558	mealTime 1007 1013	fasted
TS1623010558	mealTime 1021 1024	fed
TS223010558	food 1244 1248	food
TS623010558	drugEffect 1307 1340	dose-dependent glucose reductions
TS2823010558	drugEffect 1345 1354;1372 1408	increased glucose-stimulated insulin secretion
R1	has_effect Arg1:TS2523010558 Arg2:TS1823010558	
R2	treat Arg1:TS2523010558 Arg2:TS2623010558	
T1	drug 465 472	AZD6370
T2	dosage 475 492	20 , 60 or 180 mg
T3	modeadm 452 456	oral
T4	drug 615 622	AZD6370
T5	dosage 623 629	180 mg
T6	drug 751 758	AZD6370
T7	dosage 891 904	60 and 180 mg
T8	drug 1050 1057	AZD6370
T9	drug 1145 1152	AZD6370
T10	frequency 1058 1088	twice or four-times over 1 day
T11	drug 1196 1203	AZD6370
T12	drug 1251 1258	AZD6370
R3	no_effect_on_drug Arg1:TS223010558 Arg2:T11	
T13	drug 1290 1297	AZD6370
R4	has_effect Arg1:T13 Arg2:TS623010558	
R5	has_effect Arg1:T13 Arg2:TS2823010558	
T14	treatedDisease 376 380	T2DM
T15	treatedDisease 1426 1430	T2DM
R6	treat Arg1:T13 Arg2:T15	
